Improving Medication Adherence Through a Health Literacy-based Intervention for Coronary Heart Disease Patients
1 other identifier
interventional
60
2 countries
2
Brief Summary
This is a multi-center pilot study to examine the effectiveness of a health literacy-based intervention to improve medication adherence and self-efficacy of medication use among individuals with coronary heart disease (CHD). The specific aims are to: i) develop a health literacy-based intervention to improve medication adherence for CHD individuals with low health literacy and ii) evaluate the effects of a health literacy-based intervention on improving medication adherence and self-efficacy in CHD individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 18, 2019
CompletedFirst Submitted
Initial submission to the registry
June 27, 2019
CompletedFirst Posted
Study publicly available on registry
July 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2019
CompletedJuly 2, 2019
June 1, 2019
7 months
June 27, 2019
June 29, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline medication adherence at 4-weeks follow-up
Measured using the Chinese version of the Hill-Bone Medication Adherence Scale (HB-MAS). The HB-MAS is a self-reported measure of the extent of medication adherence. The HB-MAS consists of 9 questions with each item rated on a 4-point scale (1 = none of the time; 2 = some of the time; 3 = most of the time; and 4 = all of the time). The total score ranges from 9 (minimum) to 36 (maximum), where lower scores indicate higher levels of medication adherence.
Baseline and 4-weeks follow-up
Secondary Outcomes (1)
Change from baseline medication self-efficacy at 4-weeks follow-up
Baseline and 4-weeks follow-up
Other Outcomes (3)
Health literacy
Baseline
Perceived social support
Baseline
CHD knowledge
Baseline
Study Arms (2)
Intervention group
EXPERIMENTALAt baseline: video and education booklet. 2-weeks after enrollment: telephone call by nurse.
Control group
NO INTERVENTIONUsual care
Interventions
Participants in the intervention group will receive a: i) 30-min video about medication adherence, ii) medication adherence booklet, and iii) 2-week telephone call by a nurse.
Eligibility Criteria
You may qualify if:
- Aged ≥18 years and diagnosed with CHD.
- Currently receiving pharmacological therapy such as statins, anti-platelet and/or blood thinner, beta-blockers, calcium channel blockers, nitroglycerin, and angiotensin- converting enzyme inhibitors (ACE).
- Low health literacy score of 9 or less as measured using the short-form Mandarin Health Literacy Scale (s-MHLS).
You may not qualify if:
- History of significant cognitive impairment, psychiatric disorders, and aphasia.
- Without access to a telephone or unable to give telephone contact.
- Currently enrolled in another program or clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chinese University of Hong Konglead
- National Taiwan Universitycollaborator
Study Sites (2)
The Nethersole School of Nursing, The Chinese University of Hong Kong
Shatin, New Territories, Hong Kong
School of Nursing, National Taiwan University
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elaine Siow, PhD
Chinese University of Hong Kong
- PRINCIPAL INVESTIGATOR
Chang Nien-Tzu, PhD
National Taiwan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professional Consultant
Study Record Dates
First Submitted
June 27, 2019
First Posted
July 2, 2019
Study Start
March 18, 2019
Primary Completion
September 30, 2019
Study Completion
September 30, 2019
Last Updated
July 2, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share